找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Management of Macular Hemorrhage; Lars-Olof Hattenbach Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Anti-V

[复制链接]
查看: 7257|回复: 42
发表于 2025-3-21 16:16:09 | 显示全部楼层 |阅读模式
书目名称Management of Macular Hemorrhage
编辑Lars-Olof Hattenbach
视频video
概述Systematic overview of therapeutic approaches to macular hemorrhage under various conditions.Full coverage of risk factors, diagnostic aspects, and prognostic criteria.Informative case presentations a
图书封面Titlebook: Management of Macular Hemorrhage;  Lars-Olof Hattenbach Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Anti-V
描述.Sub- or preretinal hemorrhage involving the macula is a typical complication in a variety of ocular diseases, including age-related macular degeneration, arterial macroaneurysm, Valsalva retinopathy, and trauma. However, there is currently no consensus regarding the ideal treatment for macular hemorrhage..The purpose of this book on macular hemorrhage is twofold: it aims both to impart valuable information on pathophysiology, risk factors, diagnostic aspects, and prognostic criteria under different conditions and to provide a systematic overview of therapeutic approaches that cover the most important situations a vitreoretinal surgeon might encounter when treating patients with this disorder. Case presentations, clinical photographs, and an extensive review of the literature supplement the important information on clinical decision making, surgical techniques, and typical pitfalls and invite the reader to explore the advantages and disadvantages of various approaches to the management of macular hemorrhage..
出版日期Book 2018
关键词Anti-VEGF Agents; Minimally Invasive Surgery; Risk Factors; Sub RPE; Subretinal Hemorrhage
版次1
doihttps://doi.org/10.1007/978-3-319-65877-3
isbn_softcover978-3-030-09754-7
isbn_ebook978-3-319-65877-3
copyrightSpringer International Publishing AG, part of Springer Nature 2018
The information of publication is updating

书目名称Management of Macular Hemorrhage影响因子(影响力)




书目名称Management of Macular Hemorrhage影响因子(影响力)学科排名




书目名称Management of Macular Hemorrhage网络公开度




书目名称Management of Macular Hemorrhage网络公开度学科排名




书目名称Management of Macular Hemorrhage被引频次




书目名称Management of Macular Hemorrhage被引频次学科排名




书目名称Management of Macular Hemorrhage年度引用




书目名称Management of Macular Hemorrhage年度引用学科排名




书目名称Management of Macular Hemorrhage读者反馈




书目名称Management of Macular Hemorrhage读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:19:21 | 显示全部楼层
发表于 2025-3-22 02:03:26 | 显示全部楼层
发表于 2025-3-22 05:33:29 | 显示全部楼层
发表于 2025-3-22 11:40:41 | 显示全部楼层
Macular Haemorrhages: Natural Course and Risk Factors,Subretinal haemorrhage is a rare but serious complication that occurs in conjunction with macular diseases. The most common cause is choroidal neovascularisation (CNV) in the eyes with age-related macular degeneration (AMD). In some series, more than 80% of patients with submacular haemorrhage had underlying AMD [1, 2].
发表于 2025-3-22 15:03:36 | 显示全部楼层
Macular Translocation,Since its introduction intravitreal anti-VEGF therapy (ranibizumab, bevacizumab) for neovascular age-related macular degeneration has improved the therapeutical options and outcomes for patients with neovascular age-related macular degeneration [1–4].
发表于 2025-3-22 20:50:35 | 显示全部楼层
The Pathophysiology of Subretinal Hemorrhage,oroidal or retinal circulation or both. Different pathological entities affecting these circulatory systems as well as trauma may be the cause of SRH. Independently from the underlying trigger, SRH damages tissue through a variety of mechanisms: The presence of iron, hemosiderin, and fibrin in the b
发表于 2025-3-22 23:50:36 | 显示全部楼层
Classification of Macular Hemorrhages,the underlying pathology, commonly a choroidal neovascular membrane (CNVM), especially in AMD patients, followed by non-AMD-related CNVM and retinal arterial macroaneurysms (RAM) and (2) the extent and location of the hemorrhage including size, thickness, and location in relation to the fovea and th
发表于 2025-3-23 04:22:12 | 显示全部楼层
Subretinal Co-application of rtPA and Bevacizumab for Neovascular AMD with Submacular Hemorrhage,a macular scar with poor visual function is the usual outcome. While several surgical treatment approaches have been proposed to date, there is no general consensus regarding optimal treatment of acute SMH. Vitrectomy with subretinal co-application of recombinant tissue plasminogen activator (rtPA)
发表于 2025-3-23 07:52:54 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-28 18:50
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表